- Home
- Pathology Industry
- Pharmasset Market and Forecasts, May 2013
Industries
Top countries
Publication dates
All regions
data types
- All
- Company Data (214)
- Country Data (18)
- Industry Data
Pharmasset Market and Forecasts, May 2013
You might be interested in: hepatitis c, drug, therapeutic vaccine, more »
industry reports
country reports
» Download Public Reports
1-10 of 13 reports for Pharmasset
Drug Discovery and Development in The United States and Georgia : Innovation and Technology Trends
- Industry report
- February 2013
- 24 pages
... And acquisitions as well as portfolio planning, risk management and external scientific activities Participated in raising capital and building pharmasset from a company valued at $30 million in 2002 to $11 ...
- Industries: Drug Discovery and Development
- Countries: United States, Georgia
Pharmaceutical Business in The United States and Canada
- Industry report
- September 2011
- 9 pages
... Therapeutics (by cephalon), mor- photek (by eisai co.), And corus pharma (by gilead sciences), archemix (product acquisition by baxter) as well as the ipos of alexza pharmaceuticals, pharmasset and mako ...
- Industries: Pathology
- Countries: United States, Canada
Pharmaceutical Business in Japan, Australia and The United States
- Industry report
- September 2011
- 31 pages
... Phase 3 psi-7977 pharmasset r-7128 mericitabine ro/p psi-938 pharmasset tmc649128 inx-189 inhibitex rg-7348 roche/ligand mk-0608 merck r-1626 roche/ nm-283 novartis stopped, or under review medivir 26 idx ...
- Industries: Pathology
- Countries: Japan, Australia, United States
Silver Sector in The United States and Canada
- Industry report
- March 2011
- 10 pages
... And combined with the relative scarcity value of the nucleotide class, could position pharmasset as a leader in the second wave of hcv therapies. According to a reuters article, psi-7977 alone Showed potent ...
- Industries: Metal and Mineral
- Countries: United States, Canada
Pharmaceutical in India : Innovation and Technology Trends
- Industry report
- January 2011
- 15 pages
... Infective - protease inhibitors will sweep the hcv market, as they did in the case of aids. At least two compounds will be approved (telaprevir, boceprevir) before 2012. Alnylam intercell pharmasset vertex auto ...
The Indian Clinical Trial Market : Innovation and Technology Trends
- Industry report
- March 2012
- 28 pages
... Astellas premier research shire prolexys duramed synta neurogesx auxilium az-seroquel novartis al pharma endoceutics pain therapeutic xanodyne az crestor poniard als (advance life science) pharmasset ...
- Industries: Drug Discovery and Development
- Countries: India
Global Healthcare Sector Trends
- Industry report
- January 2012
- 12 pages
... Of hepatitis c medicines, a market that may be worth $20bn by 2020. The acquisition follows gilead sciences' to buy experimental hepatitis c drug maker pharmasset for $10,8bn at a 94% premium ...
- Industries: Healthcare
- Countries: South Africa, Africa, World
World Pharmaceutical Industry Analysis
- Industry report
- April 2012
- 84 pages
... Miss/ ok comments pharmasset na 441% na h initially on robust data in hcv and partnering and later on acquisition regeneron $70 84% op h current price presents a good investment opportunity ...
- Industries: Pharmaceutical
- Countries: World
U.S. Pharmaceutical Business Analysis
- Industry report
- July 2012
- 172 pages
- by Corporation
... pharmasset, now part of gilead 103 roche group development pipeline marketed products development programmes roche pharma global development programmes roche pharma research and early development genentech ...
- Industries: Pathology
- Countries: United States
Pharmaceutical Sector Analysis in The United States
- Industry report
- October 2012
- 159 pages
- by Corporation
... At week 12 after the end of the study treatment status Fpi q2 2012 recruitment expected to complete in q4 2012 rg7128 licensed from pharmasset, now part of gilead, setrobuvir Anadys pharmaceuticals inc ...
- Industries: Pathology
- Countries: United States
Reportlinker.com © Copyright 2013. All rights reserved.
